Nissay Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Nissay Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-14,204	Closed	-$639K	–	766
2021 Q1	$639K	Sell	14,204 -275	-2%	-$15.3K	0.01%	668
2020 Q4	$819K	Buy	14,479 +785	+6%	+$39.1K	0.01%	626
2020 Q3	$650K	Buy	13,694 +249	+2%	+$13.8K	0.01%	633
2020 Q2	$793K	Buy	13,445 +1,435	+12%	+$79.8K	0.02%	578
2020 Q1	$568K	Buy	12,010 +445	+4%	+$24.8K	0.01%	558
2019 Q4	$699K	Buy	11,565 +527	+5%	+$31.4K	0.02%	615
2019 Q3	$661K	Buy	11,038 +673	+6%	+$43.9K	0.02%	599
2019 Q2	$666K	Buy	+10,365	New	+$733K	0.02%	601

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Nissay Asset Management's IONS Position: Q2 2021 in Review

Nissay Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 14,204 shares — an estimated $639K sold.

Nissay Asset Management first reported a position in IONS in Q2 2019 and held it in 8 quarters. The position peaked at $819K in Q4 2020. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

Nissay Asset Management reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Nissay Asset Management sold 14,204 Ionis Pharmaceuticals shares in Q2 2021, an estimated $639K.
Nissay Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2019 and held it in 8 quarters.
Nissay Asset Management's Ionis Pharmaceuticals position peaked at $819K in Q4 2020.
337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Nissay Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.